Tenderwize
Back to tender search

Framework Agreement for Supply of Adalimumab and Golimumab

Consorci de Salut i d'Atenció Social de Catalunya·No consta, Spain·Expired · Jul 09, 2026·Open·Supplies·Framework
Structured notice only
Original notice title

Spain – Various medicinal products – ACUERDO MARCO DEL SUMINISTRO DE LOS MEDICAMENTOS ADALIMUMAB Y GOLIMUMAB

30/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkExpired
Why this score?

Opportunity

30 / 100

Complexity

40 / 100

Risk factors

No estimated value is provided; the true contract value is unknown, which may affect bid/no-bid decisions and resource...

Award criteria and selection criteria are not specified, making it impossible to assess the likelihood of winning or pr...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration 1 YEAR
  • Supply of various medicinal products specifically Adalimumab and Golimumab.
  • Framework agreement for multiple contracts with healthcare providers in Catalonia.
Show full summary

This tender is a framework agreement for the supply of medicinal products Adalimumab and Golimumab, managed by Consorci de Salut i d'Atenció Social de Catalunya for the Catalonia region (Spain). The procedure is open with electronic submission required. The notice lacks estimated value, award criteria, and selection criteria, increasing uncertainty. The deadline for submission is 2026-07-09T13:00:00 (local time). One lot covers all supplies. The framework agreement duration is stated as 1 year, but the XML notice suggests a possible 48-month duration, creating inconsistency.

Risks

No estimated value is provided; the true contract value is unknown, which may affect bid/no-bid decisions and resource...

Award criteria and selection criteria are not specified, making it impossible to assess the likelihood of winning or pr...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Tenders must be in Catalan (and possibly Spanish based on XML).

Administrative

  • Electronic submission is mandatory.
  • Tenders must be submitted via the provided URL.

Requirements may be incomplete.

Award Criteria

Lot 1

Award criteria not specified in the structured data or notice.

Buyer

Location

No consta, ESP

Identifier

8885209

Activity

Health

Lots (1)

LOT-0000

Framework Agreement for Supply of Adalimumab and Golimumab

Single lot covering the supply of various medicinal products, specifically Adalimumab and Golimumab. The framework agreement is for supplies, and the scope is the provision of these medicines to healthcare entities in Catalonia.

SuppliesFrameworkEU fundedElectronic submission

Location

Spain

Duration

1 YEAR

Category

Medicinal products

Award Criteria

Award criteria not specified in the structured data or notice.

Deadline

Expired Jul 09, 2026

Procurement Details

Publication date
02 Jun 2026
Languages
Spanish, Cat

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
379033-2026

Documents (1)

Similar tenders